139 related articles for article (PubMed ID: 30964100)
1. Precision dose measurement of
Zhang H; Liang Y; Qiu G; Wang Z; Dev D; Liu Z; Li H; Yu H; Chen J; Sui A; Wang J; Shi G
J Cancer Res Ther; 2019; 15(2):291-297. PubMed ID: 30964100
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo characterization of biocompatible beta-emitting 90Y glass seed incorporated with the radionuclide 153Sm as a SPECT marker for brachytherapy applications.
Hadadi A; Sadeghi M; Sardari D; Khanchi A; Shirazi A
J Appl Clin Med Phys; 2013 Sep; 14(5):90-103. PubMed ID: 24036862
[TBL] [Abstract][Full Text] [Related]
3. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
4. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
[No Abstract] [Full Text] [Related]
5. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
Chiu-Tsao ST; Medich D; Munro J
Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis.
Al-Qaisieh B; Smith DW; Brearley E; St Clair S; Bownes P
Radiother Oncol; 2007 Aug; 84(2):140-7. PubMed ID: 17588696
[TBL] [Abstract][Full Text] [Related]
7. [Brachytherapy treatment planning calculation (125)I particle esophageal stent dosimetric study].
Sun HT; Wang JJ; Lin L
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(41):3350-3353. PubMed ID: 30440127
[No Abstract] [Full Text] [Related]
8. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
Chen Z; Bongiorni P; Nath R
Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
[TBL] [Abstract][Full Text] [Related]
9. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.
Brun T; Bachaud JM; Graff-Cailleaud P; Malavaud B; Portalez D; Popotte C; Aziza R; Lusque A; Filleron T; Ken S
Brachytherapy; 2018; 17(3):544-555. PubMed ID: 29525514
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film.
Chiu-Tsao ST; Napoli JJ; Davis SD; Hanley J; Rivard MJ
Appl Radiat Isot; 2014 Sep; 92():102-14. PubMed ID: 25038559
[TBL] [Abstract][Full Text] [Related]
11. Expert consensus statement on computed tomography-guided
Wang J; Chai S; Zheng G; Jiang Y; Ji Z; Guo F; Zhuang H; Zhang K
J Cancer Res Ther; 2018 Jan; 14(1):12-17. PubMed ID: 29516952
[TBL] [Abstract][Full Text] [Related]
12. [Calculation of the surface radial dose distribution of radioactive biliary stent loaded with 125I seeds by treatment planning system].
Yao LL; Lin L; Sun HT; Wang JJ; Zhou FG; Yan XQ; Teng GJ; Guo JH
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(9):727-30. PubMed ID: 27055514
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.
Fabbri C; Sarti G; Cremonesi M; Ferrari M; Di Dia A; Agostini M; Botta F; Paganelli G
Cancer Biother Radiopharm; 2009 Feb; 24(1):145-54. PubMed ID: 19243257
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
15. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
16. [Effect of image fusion technology of radioactive particles implantation before and after the planning target and dosimetry].
Jiang YL; Yu JP; Sun HT; Guo FX; Ji Z; Fan JH; Zhang LJ; Li X; Wang JJ
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2275-2279. PubMed ID: 28780842
[No Abstract] [Full Text] [Related]
17. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity GafChromic film dosimetry for 125I seed.
Chiu-Tsao ST; de la Zerda A; Lin J; Kim JH
Med Phys; 1994 May; 21(5):651-7. PubMed ID: 7935199
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
20. Expert consensus on computed tomography-assisted three-dimensional-printed coplanar template guidance for interstitial permanent radioactive
Wang J; Chai S; Wang R; Zheng G; Zhang K; Huo B; Huo X; Jiang Y; Ji Z; Jiang P; Peng R
J Cancer Res Ther; 2019; 15(7):1430-1434. PubMed ID: 31939420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
